PARP-1 and CASP3 Genes Are Up-regulated in LNCaP and PC-3 Prostate Cancer Cell Lines

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2014 Jul 20

PMID 25037599

Citations 3

Authors

Michele Salemi

Rosita A Condorelli

Sandro La Vignera

Nunziata Barone

Federico Ridolfo

Maria C Giuffrida

Enzo Vicari

Aldo E Calogero

Affiliations

Soon will be listed here.

Citing Articles

Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancer.

Kam C, Tauber A, Zunk M, McDermott C, Levonis S, Schweiker S Future Med Chem. 2024; 17(1):35-58.

PMID: 39691063 PMC: 11703142. DOI: 10.1080/17568919.2024.2437972.

A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology.

Drozd M, Capovilla M, Previdere C, Grossi M, Askenazy F, Bardoni B Front Genet. 2022; 12:792218.

PMID: 34976023 PMC: 8719199. DOI: 10.3389/fgene.2021.792218.

Development of prognosis model for colon cancer based on autophagy-related genes.

Wang X, Xu Y, Li T, Chen B, Yang W World J Surg Oncol. 2020; 18(1):285.

PMID: 33126898 PMC: 7602324. DOI: 10.1186/s12957-020-02061-w.

References

Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M . Cancer statistics, 2003. CA Cancer J Clin. 2003; 53(1):5-26. DOI: 10.3322/canjclin.53.1.5. View

Vela-Navarrete R, Escribano-Burgos M, Farre A, Garcia-Cardoso J, Manzarbeitia F, Carrasco C . Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. J Urol. 2005; 173(2):507-10. DOI: 10.1097/01.ju.0000150533.94952.25. View

Kannan S, Fang W, Song G, Mullighan C, Hammitt R, McMurray J . Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. Blood. 2011; 117(10):2891-900. PMC: 3062299. DOI: 10.1182/blood-2009-12-253419. View

Ha H, Snyder S . Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A. 1999; 96(24):13978-82. PMC: 24176. DOI: 10.1073/pnas.96.24.13978. View

Steinberg G, Carter B, Beaty T, Childs B, Walsh P . Family history and the risk of prostate cancer. Prostate. 1990; 17(4):337-47. DOI: 10.1002/pros.2990170409. View

Marcelli M, Cunningham G, Haidacher S, Padayatty S, Sturgis L, Kagan C . Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998; 58(1):76-83. View

KAIGHN M, Narayan K, Ohnuki Y, Lechner J, Jones L . Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979; 17(1):16-23. View

Walczak J, Carducci M . Prostate cancer: a practical approach to current management of recurrent disease. Mayo Clin Proc. 2007; 82(2):243-9. DOI: 10.4065/82.2.243. View

Trojan L, Kiknavelidze K, Knoll T, Alken P, Michel M . Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res. 2005; 25(1B):551-61. View

10.

Calogero A, Soma P, Giuffrida M, Giuffrida D, La Vignera S, Romano C . PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease. Hum Cell. 2011; 26(1):44-6. DOI: 10.1007/s13577-011-0021-4. View

11.

Thornberry N, Lazebnik Y . Caspases: enemies within. Science. 1998; 281(5381):1312-6. DOI: 10.1126/science.281.5381.1312. View

12.

Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F . Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol. 1991; 146(3):881-6. DOI: 10.1016/s0022-5347(17)37953-3. View

13.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M . Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1):43-66. DOI: 10.3322/canjclin.57.1.43. View

14.

Guseva N, Taghiyev A, Rokhlin O, Cohen M . Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2003; 91(1):70-99. DOI: 10.1002/jcb.10707. View

15.

Ossovskaya V, Koo I, Kaldjian E, Alvares C, Sherman B . Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types. Genes Cancer. 2011; 1(8):812-21. PMC: 3092251. DOI: 10.1177/1947601910383418. View

16.

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

17.

Hassa P, Hottiger M . The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci. 2007; 13:3046-82. DOI: 10.2741/2909. View

18.

Kucuk O . Chemoprevention of prostate cancer. Cancer Metastasis Rev. 2002; 21(2):111-24. DOI: 10.1023/a:1020809806121. View

19.

Gallagher R, Fleshner N . Prostate cancer: 3. Individual risk factors. CMAJ. 1998; 159(7):807-13. PMC: 1232741. View

20.

Berthon P, Cussenot O, Hopwood L, Leduc A, Maitland N . Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. Int J Oncol. 2011; 6(2):333-43. DOI: 10.3892/ijo.6.2.333. View